跳至主要内容
临床试验/NCT05348304
NCT05348304已完成不适用

Hypoglycemic Effects of a Dietary Supplement That Combines the Properties of Myo-inositol and D-chiro-inositol With Gymnema Silvestre, Alpha-lactalbumin and Zinc.

Lo.Li.Pharma s.r.l1 个研究点 分布在 1 个国家目标入组 37 人开始时间: 2022年6月28日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
37
试验地点
1
主要终点
Insulinemia

研究概览

简要总结

This study is aimed at evaluating the hypoglycemic effects of a dietary supplement that associates the properties of two inositols (myo-inositol and D-chiro-inositol) in the ratio 40:1 to Gymnema sylvestre, alpha-lactalbumin and zinc.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

性别
All
接受健康志愿者
否

入选标准

  • •BMI between 30 and 35
  • •Basal Glycemia between 100 and 125 mg/dl

排除标准

  • •Diabetes diagnosis
  • •Use of food supplements containing inositols, gymnema, alpha-lactalbumin and zinc
  • •Intolerance to inositols, gymnema, alpha-lactalbumin and zinc

研究组 & 干预措施

Control

No Intervention

Hypocaloric diet

EUDIAMET

Experimental

Hypocaloric diet plus a supplementation with myo-inositol and D-chiro-inositol in the 40:1 ratio, Gymnema sylvestre, alpha-lactalbumin and zinc

干预措施: EUDIAMET (Dietary Supplement)

结局指标

主要结局

Insulinemia

时间窗: Three time points: change in insulin levels from the baseline to three and six months

Reduction of systemic insulin levels

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验